ConductScience.org, home

Paper8401490

The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.

Puck JM and 6 others. Hum Mol Genet, 1993. Cited by 229 papers, by iCite.

Cite this record

ConductScience Library. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Papers, record 8401490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8401490

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
PubMed
Journal
Hum Mol Genet
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
229
iCite
Relative citation ratio, by iCite
3.97
iCite
Revised in PubMed
2019-05-12
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Puck JMJ M
2Deschênes SMS M
3Porter JCJ C
4Dutra ASA S
5Brown CJC J
6Willard HFH F
7Henthorn PSP S

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic LinkageMajor topic
Point MutationMajor topic
Receptors, Interleukin-2Major topic
Severe Combined ImmunodeficiencyMajor topic
X ChromosomeMajor topic
Amino Acid Sequence
Base Sequence
Chromosome Mapping
Chromosomes, Artificial, Yeast
Cloning, Molecular
DNA Primers
Exons
Female
Gene Library
Humans
In Situ Hybridization
Lymphocytes
Macromolecular Substances
Male
Molecular Sequence Data
Pedigree
Polymerase Chain Reaction

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA09615NCI NIH HHSUnited StatesT32CA009615PubMed and NIHNIH RePORTER
HD23679NICHD NIH HHSUnited StatesR01HD023679PubMed and NIHNIH RePORTER
HG00233NHGRI NIH HHSUnited StatesR01HG000233PubMed and NIHNIH RePORTER

Download CSV of grants

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00006335Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCIDBackgroundClinicalTrials.gov
NCT00028236Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)BackgroundClinicalTrials.gov
NCT00128973Evaluation of Patients With Immune Function AbnormalitiesBackgroundClinicalTrials.gov

Download CSV of trials

Cited by76

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 229 citations.

PMIDTitleJournalYearIn PapersSource
42797625Stepwise Evolution of Immunodeficient Mouse Models: Focus on NCG Strains and Their Applications in Humanized Immune System Research.Vaccines (Basel)2026https://conductscience.org/library/papers/42797625PubMed
39967341Targeting γc family cytokines with biologics: current status and future prospects.MAbs2025https://conductscience.org/library/papers/39967341PubMed
39720273Novel IL2RG gene mutation causing primary combined immunodeficiency disease: A case report and literature review.Cent Eur J Immunol2024https://conductscience.org/library/papers/39720273PubMed
39450341Case of T-B+NK+ X-Linked Severe Combined Immunodeficiency Disease.Case Rep Med2024https://conductscience.org/library/papers/39450341PubMed
38166538ZSCAN25 methylation predicts seizures and severe alcohol withdrawal syndrome.Epigenetics2024https://conductscience.org/library/papers/38166538PubMed
38022498Too much of a good thing: a review of primary immune regulatory disorders.Front Immunol2023https://conductscience.org/library/papers/38022498PubMed
37863939Inborn errors of immunity: an expanding universe of disease and genetic architecture.Nat Rev Genet2024https://conductscience.org/library/papers/37863939PubMed
36553615Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.Genes (Basel)2022https://conductscience.org/library/papers/36553615PubMed
35764638Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency.Nat Commun2022https://conductscience.org/library/papers/35764638PubMed
35498802Novel IL2RG Gene Mutation in One of Dizygotic Twins Causing Profound Changes of Receptor Structure.Front Pediatr2022https://conductscience.org/library/papers/35498802PubMed
35052377Somatic Reversion of a Novel IL2RG Mutation Resulting in Atypical X-Linked Combined Immunodeficiency.Genes (Basel)2021https://conductscience.org/library/papers/35052377PubMed
34248995Case Report: Interleukin-2 Receptor Common Gamma Chain Defect Presented as a Hyper-IgE Syndrome.Front Immunol2021https://conductscience.org/library/papers/34248995PubMed
33329605Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.Front Immunol2020https://conductscience.org/library/papers/33329605PubMed
31799703The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype.Clin Exp Immunol2020https://conductscience.org/library/papers/31799703PubMed
31304419Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management.Int J Neonatal Screen2017https://conductscience.org/library/papers/31304419PubMed
30995372Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.N Engl J Med2019https://conductscience.org/library/papers/30995372PubMed
30850927A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency.Int J Hematol2019https://conductscience.org/library/papers/30850927PubMed
30261899T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency.Genome Med2018https://conductscience.org/library/papers/30261899PubMed
30191136Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering.World J Clin Pediatr2018https://conductscience.org/library/papers/30191136PubMed
29606506Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.Mol Ther2018https://conductscience.org/library/papers/29606506PubMed

See all 76 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL2RG3561Swiss-Prot's referenceshttps://conductscience.org/library/genes/3561NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8401490

GET https://conductscience.org/api/papers/v1/8401490/cited_by?page=2